亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Association of Mid- to Late-Life Blood Pressure Patterns With Risk of Subsequent Coronary Heart Disease and Death

心脏病学 风险因素 心肌梗塞 弗雷明翰风险评分 优势比 死因 冠状动脉疾病 置信区间 人口 心力衰竭 混淆
作者
Menghui Liu,Shaozhao Zhang,Xiaohong Chen,Xiangbin Zhong,Zhenyu Xiong,Daya Yang,Yifen Lin,Yiquan Huang,Yuqi Li,Lichun Wang,Xiaodong Zhuang,Xinxue Liao
出处
期刊:Frontiers in Cardiovascular Medicine [Frontiers Media SA]
卷期号:8: 632514-632514 被引量:1
标识
DOI:10.3389/fcvm.2021.632514
摘要

Background: The elevated blood pressure (BP) at midlife or late-life is associated with cardiovascular disease and death. However, there is limited research on the association between the BP patterns from middle to old age and incident coronary heart disease (CHD) and death. Methods: A cohort of the Atherosclerosis Risk in Communities (ARIC) Study enrolled 9,829 participants who attended five in-person visits from 1987 to 2013. We determined the association of mid- to late-life BP patterns with incident CHD and all-cause mortality using multivariable-adjusted Cox proportional hazards models. Results: During a median of 16.7 years of follow-up, 3,134 deaths and 1,060 CHD events occurred. Compared with participants with midlife normotension, the adjusted hazard ratio for all-cause mortality and CHD was 1.14 (95% CI, 1.04-1.25) and 1.28 (95% CI, 1.10-1.50) in those with midlife hypertension, respectively. In further analyses, compared with a pattern of sustained normotension from mid- to late-life, there was no significant difference for the risk of incident death (HR, 1.15; 95% CI, 0.96-1.37) and CHD (HR, 1.33; 95% CI, 0.99-1.80) in participants with a pattern of midlife normotension and late-life hypertension with effective BP control. A higher risks of death and CHD were found in those with pattern of mid- to late-life hypertension with effective BP control (all-cause mortality: HR, 1.24; 95% CI, 1.08-1.43; CHD: HR, 1.65; 95% CI 1.30-2.09), pattern of midlife normotension and late-life hypertension with poor BP control (all-cause mortality: HR, 1.27; 95% CI, 1.12-1.44; CHD: HR, 1.53; 95% CI, 1.23-1.92), and pattern of mid- to late-life hypertension with poor BP control (all-cause mortality: HR, 1.49; 95% CI, 1.30-1.71; CHD: HR, 1.87; 95% CI, 1.48-2.37). Conclusions: The current findings underscore that the management of elderly hypertensive patients should not merely focus on the current BP status, but the middle-aged BP status. To achieve optimal reductions in the risk of CHD and death, it may be necessary to prevent, diagnose, and manage of hypertension throughout middle age.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
曾经的亿先完成签到,获得积分10
6秒前
Singularity应助小葵采纳,获得10
12秒前
小丫头大傻妞完成签到 ,获得积分10
13秒前
18秒前
20秒前
hhhh发布了新的文献求助10
24秒前
西门发发发布了新的文献求助10
26秒前
蒙豆儿完成签到,获得积分10
27秒前
ellen完成签到,获得积分10
28秒前
34秒前
无花果应助西门发发采纳,获得30
35秒前
蒙豆儿发布了新的文献求助10
39秒前
42秒前
48秒前
48秒前
48秒前
49秒前
新楚完成签到,获得积分10
51秒前
neuarcher给Yang的求助进行了留言
53秒前
Lucas应助科研通管家采纳,获得10
54秒前
在水一方应助科研通管家采纳,获得10
54秒前
CipherSage应助科研通管家采纳,获得10
54秒前
紫zi完成签到 ,获得积分10
57秒前
自信的傲晴完成签到,获得积分10
58秒前
筱溪完成签到 ,获得积分10
1分钟前
GT完成签到,获得积分10
1分钟前
1分钟前
含糊的冰彤完成签到,获得积分20
1分钟前
Kevin完成签到,获得积分10
1分钟前
嗯哼应助Fury采纳,获得10
1分钟前
77完成签到,获得积分10
1分钟前
lixiaolu完成签到 ,获得积分10
1分钟前
蹀躞完成签到 ,获得积分10
1分钟前
Panini完成签到 ,获得积分10
1分钟前
在水一方应助oleskarabach采纳,获得10
1分钟前
1分钟前
2分钟前
BW发布了新的文献求助10
2分钟前
BW完成签到,获得积分10
2分钟前
彭于晏应助Tao122采纳,获得10
2分钟前
高分求助中
Evolution 2024
Impact of Mitophagy-Related Genes on the Diagnosis and Development of Esophageal Squamous Cell Carcinoma via Single-Cell RNA-seq Analysis and Machine Learning Algorithms 2000
How to Create Beauty: De Lairesse on the Theory and Practice of Making Art 1000
Gerard de Lairesse : an artist between stage and studio 670
大平正芳: 「戦後保守」とは何か 550
Angio-based 3DStent for evaluation of stent expansion 500
Populist Discourse: Recasting Populism Research 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 2993803
求助须知:如何正确求助?哪些是违规求助? 2654426
关于积分的说明 7179925
捐赠科研通 2289597
什么是DOI,文献DOI怎么找? 1213649
版权声明 592704
科研通“疑难数据库(出版商)”最低求助积分说明 592351